# Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway

> **NCT04070053** · NA · COMPLETED · sponsor: **University of Calgary** · enrollment: 920 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome
- Hypoxemic Respiratory Failure
- ARDS, Human

## Interventions

- **OTHER:** TheraPPP Pathway

## Key facts

- **NCT ID:** NCT04070053
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-23
- **Primary completion:** 2021-03-16
- **Final completion:** 2022-03-30
- **Target enrollment:** 920 (ACTUAL)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04070053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04070053, "Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04070053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*